MoneyWorks4Me

Colinz Laboratories - Quaterly Results

04 Nov 2025 Evaluate
Net sales declined -25.50%  to  Rs. 13.88 million from Rs. 18.63 millions.The Company's Net profit for the September 2025 quarter have declined marginally to Rs. 1.40  millions as against Rs. 1.56 millions reported during the corresponding quarter ended.Operating Profit reported a sharp decline to 2.38 millions from 2.52 millions in the corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202509 202409 % Var 202509 202409 % Var 202503 202403 % Var
Sales 13.88 18.63 -25.50 29.54 36.10 -18.17 65.28 70.30 -7.14
Other Income 1.59 0.78 103.85 2.34 1.45 61.38 2.98 2.75 8.36
PBIDT 2.38 2.52 -5.56 4.49 4.78 -6.07 7.94 8.17 -2.82
Interest 0.13 0.12 8.33 0.25 0.21 19.05 0.42 0.37 13.51
PBDT 2.25 2.40 -6.25 4.24 4.57 -7.22 7.52 7.80 -3.59
Depreciation 0.39 0.32 21.88 0.78 0.64 21.88 1.31 1.30 0.77
PBT 1.86 2.08 -10.58 3.46 3.93 -11.96 6.21 6.50 -4.46
TAX 0.46 0.52 -11.54 0.88 1.00 -12.00 1.23 1.64 -25.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 -0.52 -0.02 2500.00
PAT 1.40 1.56 -10.26 2.58 2.93 -11.95 4.98 4.86 2.47
Equity 25.19 25.19 0.00 25.19 25.19 0.00 25.19 25.19 0.00
PBIDTM(%) 17.15 13.53 26.77 15.20 13.24 14.79 12.16 11.62 4.66
Peers
Company Name CMP
Sun Pharma. Inds. 1840.00
Dr. Reddys Labs. 1222.50
Cipla 1388.90
Lupin 2061.85
Zydus Lifesciences 1212.00
View more..